Showing 13,841 - 13,860 results of 226,405 for search '(( a ((a decrease) OR (linear decrease)) ) OR ( a ((larger decrease) OR (greatest decrease)) ))', query time: 1.71s Refine Results
  1. 13841

    Table_3_MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.DOCX by Benrong Liu (200777)

    Published 2022
    “…Silencing MEF2A in VE of apoE<sup>−/−</sup> mice decreased the expression of SIRT1, increased the plasma LDL-c, and abrogated the function of resveratrol on reducing triglyceride. …”
  2. 13842

    Table_9_MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.XLSX by Benrong Liu (200777)

    Published 2022
    “…Silencing MEF2A in VE of apoE<sup>−/−</sup> mice decreased the expression of SIRT1, increased the plasma LDL-c, and abrogated the function of resveratrol on reducing triglyceride. …”
  3. 13843

    Table_5_Pathogenesis of Enamel-Renal Syndrome Associated Gingival Fibromatosis: A Proteomic Approach.pdf by Victor Simancas Escorcia (9741794)

    Published 2021
    “…<p>The enamel renal syndrome (ERS) is a rare disorder featured by amelogenesis imperfecta, gingival fibromatosis and nephrocalcinosis. …”
  4. 13844

    Table_1_Pathogenesis of Enamel-Renal Syndrome Associated Gingival Fibromatosis: A Proteomic Approach.docx by Victor Simancas Escorcia (9741794)

    Published 2021
    “…<p>The enamel renal syndrome (ERS) is a rare disorder featured by amelogenesis imperfecta, gingival fibromatosis and nephrocalcinosis. …”
  5. 13845

    Table_7_MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.DOCX by Benrong Liu (200777)

    Published 2022
    “…Silencing MEF2A in VE of apoE<sup>−/−</sup> mice decreased the expression of SIRT1, increased the plasma LDL-c, and abrogated the function of resveratrol on reducing triglyceride. …”
  6. 13846

    Table_5_MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.DOCX by Benrong Liu (200777)

    Published 2022
    “…Silencing MEF2A in VE of apoE<sup>−/−</sup> mice decreased the expression of SIRT1, increased the plasma LDL-c, and abrogated the function of resveratrol on reducing triglyceride. …”
  7. 13847

    Table_6_MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.XLSX by Benrong Liu (200777)

    Published 2022
    “…Silencing MEF2A in VE of apoE<sup>−/−</sup> mice decreased the expression of SIRT1, increased the plasma LDL-c, and abrogated the function of resveratrol on reducing triglyceride. …”
  8. 13848

    Table_2_MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.XLSX by Benrong Liu (200777)

    Published 2022
    “…Silencing MEF2A in VE of apoE<sup>−/−</sup> mice decreased the expression of SIRT1, increased the plasma LDL-c, and abrogated the function of resveratrol on reducing triglyceride. …”
  9. 13849

    Table_6_Pathogenesis of Enamel-Renal Syndrome Associated Gingival Fibromatosis: A Proteomic Approach.pdf by Victor Simancas Escorcia (9741794)

    Published 2021
    “…<p>The enamel renal syndrome (ERS) is a rare disorder featured by amelogenesis imperfecta, gingival fibromatosis and nephrocalcinosis. …”
  10. 13850

    Data_Sheet_3_Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfu... by Yinliang Chen (12266894)

    Published 2022
    “…<p>Diabetic cardiomyopathy (DCM) is a primary cause of death in diabetic patients; however, its molecular mechanism is not yet clear, and there is no uniform standard for diagnosis. …”
  11. 13851

    Data_Sheet_8_Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfu... by Yinliang Chen (12266894)

    Published 2022
    “…<p>Diabetic cardiomyopathy (DCM) is a primary cause of death in diabetic patients; however, its molecular mechanism is not yet clear, and there is no uniform standard for diagnosis. …”
  12. 13852

    Data_Sheet_9_Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfu... by Yinliang Chen (12266894)

    Published 2022
    “…<p>Diabetic cardiomyopathy (DCM) is a primary cause of death in diabetic patients; however, its molecular mechanism is not yet clear, and there is no uniform standard for diagnosis. …”
  13. 13853

    Table_1_Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfunctio... by Yinliang Chen (12266894)

    Published 2022
    “…<p>Diabetic cardiomyopathy (DCM) is a primary cause of death in diabetic patients; however, its molecular mechanism is not yet clear, and there is no uniform standard for diagnosis. …”
  14. 13854

    Data_Sheet_2_MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.PDF by Benrong Liu (200777)

    Published 2022
    “…Silencing MEF2A in VE of apoE<sup>−/−</sup> mice decreased the expression of SIRT1, increased the plasma LDL-c, and abrogated the function of resveratrol on reducing triglyceride. …”
  15. 13855

    Data_Sheet_2_Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfu... by Yinliang Chen (12266894)

    Published 2022
    “…<p>Diabetic cardiomyopathy (DCM) is a primary cause of death in diabetic patients; however, its molecular mechanism is not yet clear, and there is no uniform standard for diagnosis. …”
  16. 13856

    Data_Sheet_1_MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.PDF by Benrong Liu (200777)

    Published 2022
    “…Silencing MEF2A in VE of apoE<sup>−/−</sup> mice decreased the expression of SIRT1, increased the plasma LDL-c, and abrogated the function of resveratrol on reducing triglyceride. …”
  17. 13857

    Table_2_Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfunctio... by Yinliang Chen (12266894)

    Published 2022
    “…<p>Diabetic cardiomyopathy (DCM) is a primary cause of death in diabetic patients; however, its molecular mechanism is not yet clear, and there is no uniform standard for diagnosis. …”
  18. 13858

    Data_Sheet_6_Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfu... by Yinliang Chen (12266894)

    Published 2022
    “…<p>Diabetic cardiomyopathy (DCM) is a primary cause of death in diabetic patients; however, its molecular mechanism is not yet clear, and there is no uniform standard for diagnosis. …”
  19. 13859

    Data_Sheet_4_Identification and Analysis of Hub Genes in Diabetic Cardiomyopathy: Potential Role of Cytochrome P450 1A1 in Mitochondrial Metabolism and STZ-Induced Myocardial Dysfu... by Yinliang Chen (12266894)

    Published 2022
    “…<p>Diabetic cardiomyopathy (DCM) is a primary cause of death in diabetic patients; however, its molecular mechanism is not yet clear, and there is no uniform standard for diagnosis. …”
  20. 13860

    Data_Sheet_3_MEF2A Is the Trigger of Resveratrol Exerting Protection on Vascular Endothelial Cell.PDF by Benrong Liu (200777)

    Published 2022
    “…Silencing MEF2A in VE of apoE<sup>−/−</sup> mice decreased the expression of SIRT1, increased the plasma LDL-c, and abrogated the function of resveratrol on reducing triglyceride. …”